Corporate News: Omnicell (OMCL) Trading Update
Trading Performance (24 h ending 10:03 AM Central Europe, Friday 23rd)
Omnicell shares rose 2.09 %.
Current price: USD 37.10.
Market capitalization: USD 1.7 bn.
Total shares outstanding: 45.5 million.
24‑hour trading volume: USD 15.9 mn.
Year‑to‑date change (since last month end): +12.46 %.
200‑day simple moving average: USD 39.44.
52‑week high: USD 55.00 (recorded 13 January 2026).
52‑week low: USD 29.09 (recorded 29 October 2025).
Peer Performance (24 h)
| Symbol | Company | % Change | Current Price | Market Cap (USD bn) |
|---|---|---|---|---|
| MTX | Minerals Technologies Inc. | +1.33 % | 64.07 | 2.0 |
| XERS | Xeris Biopharma | –3.05 % | 10.86 | 2.0 |
| MRVI | Maravai Lifesciences | +5.14 % | 7.07 | 2.0 |
| BCRX | Biocryst | +0.39 % | 7.78 | 2.0 |
| SRPT | Sarepta Therapeutics | –2.05 % | 18.18 | 2.0 |
Minerals Technologies Inc. Dividend Announcement
On 21 October, the board increased the regular quarterly dividend by 8 % to $0.13 per share.
Dividend payout date: 3 December 2026.
Record date: 5 November 2026.
The company emphasized confidence in steady cash flow and a broader capital‑deployment strategy that includes share repurchases, dividends, and both organic and inorganic investments.
Announcement released via Globe Newswire from headquarters in New York.
Company Profile: Omnicell, Inc.
A health‑care technology provider focused on integrated clinical infrastructure and workflow automation solutions.
Offers pharmacy and supply systems, clinical reference tools, an internet‑based procurement application, and decision‑support tools.
Products and services are sold and leased to healthcare facilities.
Listed on the Nasdaq stock exchange.
IPO date: 7 August 2001.
Official website: www.omnicell.com .